February 3, 4, and 5, 2002
Napa Valley Lodge
Yountville, CA
"Intellectual property and the Consortium" Dr. Mark Rohrbaugh, Head, Office of Technology Transfer, NIH, and Winifred Rossi from NIA
"SIR2" Leonard Guarente
"Telomeres and telomerase: their impacts on cell proliferation" Elizabeth Blackburn
"Telomere measurement by quantitative PCR" Richard Cawthon
"Can programmed cell death teach us anything about programmed organismal death (aging)?" Dale Bredesen
"Growth hormone deficient mice" Andrzej Bartke
"Phenotypes - How cataracts serve as a marker for aging and longevity" Barbara Klein
"Werner's and aging" Junko Oshima
"Longevity, late fertility and other indicators of slow aging in humans" Ken Smith
"Chromosome 4" Tom Perls
"Improving Case-Control Studies: Haplotype Analysis and Sample Homogeneity Assessment" Nik Schork
"Coenzyme Q and Longevity" Pamela Larsen
"Lessons from studies of the genetic basis of hypertension" Dave Curb
"Cell stress genes and longevity" Gordon Lithgow
"Phenotypes - Physiological measures from the Sonoma Study of Aging" Milton Hollenberg
"Biomarker Phenotypes - Aging and compensation: what doesn't kill you won't necessarily make you stronger" Tamara Harris
"Proposed experiment: insulin pathways" Elad Ziv
"Future funding of experiments through the Consortium. Feasibility of a UO-1 submission" NIA Program Staff: Evan Hadley, Huber Warner, Anna McCormick, and Winnie Rossi